ACHILLION PHARMACEUTICALS IN's ticker is and the CUSIP is 00448Q951. A total of 4 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $193,000 | +132.5% | 24,800 | +129.6% | 0.00% | – |
| Q1 2016 | $83,000 | -84.1% | 10,800 | -77.6% | 0.00% | -100.0% |
| Q4 2015 | $521,000 | +65.4% | 48,300 | +5.9% | 0.00% | – |
| Q3 2015 | $315,000 | -26.9% | 45,600 | -6.2% | 0.00% | – |
| Q2 2015 | $431,000 | -30.6% | 48,600 | -22.9% | 0.00% | -100.0% |
| Q1 2015 | $621,000 | -53.2% | 63,000 | -41.8% | 0.00% | 0.0% |
| Q4 2014 | $1,327,000 | -3.6% | 108,300 | -21.5% | 0.00% | 0.0% |
| Q3 2014 | $1,377,000 | +669.3% | 138,000 | +484.7% | 0.00% | – |
| Q2 2014 | $179,000 | +411.4% | 23,600 | +120.6% | 0.00% | – |
| Q1 2014 | $35,000 | -30.0% | 10,700 | -29.1% | 0.00% | – |
| Q4 2013 | $50,000 | -20.6% | 15,100 | -27.1% | 0.00% | – |
| Q3 2013 | $63,000 | -74.9% | 20,700 | -32.6% | 0.00% | – |
| Q2 2013 | $251,000 | – | 30,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,938 | $3,930,000 | 0.15% |
| GROUP ONE TRADING, L.P. | 670,000 | $6,687,000 | 0.10% |
| Citadel Advisors | 138,000 | $1,377,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 5,000 | $49,000 | 0.00% |